TABLE 1.

In Vivo Characterization of [177Lu]Lu-Gemini and Calculated Mouse Dosimetry for Kidney, Blood, and Bone Marrow

DOTA-radiohaptenBlood half-life (min)Whole-body half-life (min)Kidney uptake 3 h after injection (%IA/g)Kidney dosimetry (mGy/MBq)Blood dosimetry (mGy/MBq)Bone marrow dosimetry (mGy/MBq)
[177Lu]Lu-Gemini10.1229.060.57 ± 0.29100.880.970.35
[177Lu]Lu-DOTA-Bn11.9427.460.59 ± 0.45104.781.060.38
  • For comparison, [177Lu]Lu-DOTA-Bn was investigated using the identical protocol.